Skip to main content
. 2024 Mar 7;109(8):2401–2419. doi: 10.3324/haematol.2022.282363

Table 1.

Most frequently used non-specific health-related quality of life tools and the specific MDASI CAR tool, in chimeric antigen receptor T-cell targeting CD19 therapy clinical studies enrolling adults.

graphic file with name 1092401.tab1.jpg